Zusammenfassung
Aus epidemiologischer und tumorbiologischer Sicht muss zwischen Plattenepithel- und Adenokarzinomen der Speiseröhre unterschieden werden. Die grundsätzlichen chirurgischen Therapieprinzipien sind allerdings für beide Tumoren ähnlich. Bei beiden gilt die R0-Resektion als wesentliches chirurgisches Therapieziel. Dieses kann bei T1- und T2-Tumoren sicher erreicht werden. Bei lokal fortgeschrittenen Tumoren (T3 und T4) werden derzeitig neoadjuvante Therapieprinzipien erprobt. Von dieser Therapie profitieren Patienten, die auf die Vorbehandlung mit einer Tumorreduktion („Downsizing “ oder gar „Down-Staging“) ansprechen. So genannte „Non-Responder“ haben eine schlechte Prognose. Ihnen steht nur eine palliative Therapie zur Verfügung.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aikou T, Shimazu H (1989) Difference in main lymphatic pathways from the lower esophagus and gastric cardia. Jpn J Surg 19: 290–295
Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y (1994) Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220: 364–372
Baba M, Aikou T, Yoshinak H, Natsugo S, Fukumoto T, Shimazu H, Akazawa K (1964) Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 219: 310–316
Brücher BLDM (2009) Plattenepithelkarzinom des Ösophagus. Chirurg 11:1011–1018
Allum WH, Stenning SP, Bancewicz J et al. (2009) Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 27:5062–5067
Ando N, Iizuka T, Ide H et al. (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 21:4592–4596
Ando N, Iizuka T, Kakegawa T et al. (1997) A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 114:205–259
Bartels H, Stein HJ, Schömig A, Siewert JR (1997) Chirurgie bei Risikopatienten unter Notfall-und Elektivbedingungen: Risikoerfassung. Chirurg 68: 654–661
Bartels H, Stein HJ, Siewert JR (1998a) Frühextubation versus Spätextubation nach Resektion beim Ösophaguscarcinom. Langenbecks Arch Chir 115[Suppl 2] 1074–1076
Bartels H, Stein HJ, Siewert JR (1998b) Preoperative risk-analysis and postoperative mortality of osophagectomy for respectable oesophageal cancer. Br J Surg 85: 840–844
Bartels H, Stein HJ, Siewert JR (1998c) Tracheobronchial lesions following oesophagectomy: Predisposing factors, respiratory management and outcome. Br J Surg 85: 403–406
Bedenne L, Michel P, Bouché O et al. (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168
Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346: 1128–1137
Bollschweiler E, Hölscher AH (2000) Deutliche Zunahme des Adenokarzinoms im Ösophagus. Dtsch Arztebl 97: A1896–A1900
Bollschweiler E, Metzger R, Drebber U et al. (2009) Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis. Ann Oncol 20:231–238
Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 337: 161–167
Brücher BLDM, Stein HJ, Bartels H, Feussner H, Siewert JR (2001) Achalasia and esophageal cancer. Incidence, prevalence, and prognosis. World J Surg 25: 745–749
Brücher BLDM, Stein HJ, Werner M, Siewert JR (2001) Lymphatic vessel invasion is an independent prognostic factor in patients with primary resected esophageal squamous cell cancer. Cancer 92: 2228–2233
Brücher BLDM, Weber W, Bauer M, Fink U, Avril N, Stein HJ, Werner M, Zimmermann F, Siewert JR, Schwaiger M (2001) Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 233: 300–309
Burmeister B, Smithers M, Gebski V et al. (2005) A randomised phase III study comparing surgery alone with chemoradiation therapy followed by surgery for resectable carcinoma of the oesophagus: an intergroup study of the Trans-Tasman Radiation Oncology Group (TROG) and the Australasian Gastro-Intestinal Trials Group (AGITG). Lancet Oncol 6: 659–668
Daly JD, Fry WA, Little AG, Winchester DP, McKee RF, Stewart AK, Fremgen A M (2000) Esophageal cancer: results of an American College of Surgeons patient care evaluation study. J Am Coll Surg 190: 562–573
Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049–2053
Dittler HJ, Siewert JR (1993) Role of endoscopic ultrasonography in esophageal cancer. Endoscopy 25: 156–161
Ell C, May A, Gossner L et al. (2000) Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett’s esophagus. Gastroenterology 118: 670–677
Feith M, Werner M, Rosenberg R, Roder JD, Stein HJ (2000) Lymph node ‚micrometastases ‘and ‚microinvolvement ‘in esophageal carcinoma. Onkologie 13: 330–333
Feith M, Stein HJ, Siewert JR (2003) Pattern of lymphatic spread in Barrett’s cancer. World J Surg 27: 1052–1057
Fiorica F, Di Bona D, Schepis F et al. (2004) Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and metaanalysis. Gut 53: 925–930
Fujita H, Kakegawa T, Yamana H, Shima I (1994) Lymph node compartments as guidelines of lymphadenectomy for esophageal carcinoma. Dis Esoph 7: 169–177
Fujita H, Kakegawa T, Yamana H et al. (1995) Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Ann Surg 222: 654–662
Fumagalli U and panel of experts (1996) Resective surgery for cancer of the thoracic esophagus. Results of a consensus conference. Dis Esoph 9: 3–19
Hamilton SR, Aaltonen L (eds) (2000) World Health Organization classification of tumours: patholgy and genetics-tumours of the digestive system. IARC, Lyon
Gebski V, Burmeister B, Smithers BM et al. (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226–234
Heidecke CD, Weighardt H, Feith M, Fink U, Zimmermann F, Stein HJ, Siewert JR, Holzmann, B (2002) Neoadjuvant treatment of esophageal cancer: Immunosuppresion following combined radiochemotherapy. Surgery 132: 495–501
Hölscher AH, Bollschweiler E, Bumm R, Bartels H, Siewert JR (1995a) Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 118: 845–855
Hölscher AH, Bollschweiler E, Schneider PM, Siewert JR (1995b) Prognosis of early esophageal cancer. Cancer 76: 178–186
Hölscher AH, Becker K, Höfler H, Fink U, Siewert JR (1996) Plattenepithel-Frühcarcinom des Ösophagus. Multizentrizität, Metastasierungsmuster und Prognose. Chirurg 67: 357–361
Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF et al. (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347: 1662–1669
Japanese Society for Esophageal Diseases (1976) Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. Jpn J Surg 6: 69–78
Kauer WK H, Stein HJ, Bartels H, Siewert JR (2003) Intratracheal lomgterm pH monitoring: A new method to evaluate episodes of silent acid aspiration in patients after esophagectomy and gastric pull up. J Gastrointest Surg 7: 599–602
Kelsen DP, Ginsberg R, Pajak TF et al. (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339: 1979–1984
Kelsen DP, Winter KA, Gunderson LL et al. (2007) Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 25: 3719–3725
Kitajima M, Kitagawa Y (2002) Surgical treatment of esophageal cancer-the advent of the era of individualization. N Engl J Med 347: 1705–1709
Lagergren J, Bergstrom R, Nyren O (1999a) Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130: 883–890
Lagergren JL, Bergstrom R, Lindgren A, Nyren (1999b) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340: 825–831
Law S, Fok M, Chow S, Chu KM, Wong J (1997) Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114: 210–217
Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D (1994) A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73: 1779–1784
Liebermann-Meffert D, Duranceau A, Stein HJ (2001) Anatomy and embryology of the esophagus. In: Orringer MB, Heitmiller R (eds) Shackelford’s surgery of the alimentary tract; vol 1, 5th edn. WB Saunders, Philadelphia, pp 3–39
Lordick F (2005) Neoadjuvant therapy for squamous cell carcinoma of the esophagus. Chirurg 76:1025–1032
Lordick F (2009) Principles of neoadjuvant therapy. Chirurg 80: 1000–1005
Lordick F, Stein HJ, Peschel C, Siewert JR (2004) Neoadjuvant therapy for oesophagogastric cancer. Br J Surg 91:540–451
Lordick F, Ott K, Krause BJ et al. (2007) Use of PET to assess early metabolic response and to guide treatment of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: the MUNICON phase II trial. Lancet Oncology 8:797–805
Medical Research Council, Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359: 1727–1733
Mueller JD, Stein HJ, Quyang T, Natsugoe S, Feith M, Werner M, Siewert JR (2000) Frequency and clinical impact of lymph node micrometastases and tumor cell microinvolvement in adenocarcinoma of the esophagogastric junction. Cancer 89: 1874–1888
Natsugoe S, Mueller J, Stein HJ, Feith M, Höfler H, Siewert JR (1998) Micrometastasis and tumor cell microinvolvement of lymph nodes esophageal squamous cell cancer: Frequency, associated tumor characteristics and impact on prognosis. Cancer 83: 858–866
Nishimaki T, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoractic esophagus. Am J Surg 175: 47–51
Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A (1992) Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16: 1104–1109
Ott K, Lordick F, Molls M et al. (2009) Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg 96(3):258–266
Rahden BHA von, Stein HJ, Siewert JR (2003) Barrett’s esophagus and Barrett’s carcinoma. Curr Oncol Rep 5:203–209
Riedel M, Stein HJ, Mounyam L, Lembeck R, Siewert JR (2001) Extensive sampling improves preoperative bronchoscopic assessment of airway invasion by supracarinal esophageal cancer: a prospective study in 166 patients. Chest 119: 1652–1660
Roder JD, Busch R, Stein HJ, Fink U, Siewert JR (1994) Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the esophagus. Br J Surg 81: 410–413
Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S (1988) Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96: 242–248
Schröder W, Vallbohmer D, Bludau M et al. (2008) The resection of the azygos vein-necessary or redundant extension of transthoracic esophagectomy? J Gasrointest Surg 12:1163–1167
Shaheen N, Ransohoff DF (2002) Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA 287:1972–1981
Siewert JR, Stein HJ (1997) Barrett’s cancer: indications, extent and results of surgical resection. Sem Surg Oncol 13: 245–252
Siewert JR, Stein HJ (1998) Classification of carcinoma of the esophagogastric junction. Br J Surg 85: 1457–1459
Siewert JR, Stein HJ (1999) Lymphadenectomy for esophageal cancer. Langenbecks Arch Surg 384: 141–148
Siewert JR, Stein HJ, Feith M, Brücher BLDM, Bartels H, Fink U (2001) Tumor cell type is an independent prognostic parameter in esophageal cancer: lessons learned from more than 1000 consecutive resections at a single institution in the Western world. Ann Surg 234: 360–369
Siewert JR, Stein HJ, Sendler A, Molls M, Fink U (2002) Esophageal cancer: clinical management. In: Kelsen DA et al. (eds) Gastrointestinal oncology: principles and practice. Lippincott Williams & Wilkins, Philadelphia, pp 261–288
Siewert JR, Bartels H, Bollschweiler E, Dittler HJ, Fink U, Hölscher AH, Roder JD (1992) Plattenepithelcarcinom des Ösophagus: Behand lungskonzepte der Chirurgischen Klinik der Technischen Universität München. Chirurg 63: 693–699
Siewert JR, Hölscher AH, Bollschweiler E, Stein HJ, Fink U (1994) Chirurgie des Barrett Carcinoms. Chirurg 66: 102–109
Siewert JR, Lordick F (2006) Response prediction-early response evaluation. Consequences for surgical oncology. Chirurg 77:1095–1103
Siewert JR, Stein HJ, Liebermann D, Bartels H (1995) The gastric tube as esophageal substitute. Dis Esoph 8: 11–19
Siewert JR, Stein HJ, Sendler A (1997) Chirurgische Relevanz bildgebender Diagnostik bei Tumoren des Gastrointestinaltrakts-Entscheidungswege beim Ösophagus-, Magen, Colon-und Rektumcarcinom. Chirurg 68: 317–324
Siewert JR, Feith M, Werner M, Stein HJ (2000) Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 232: 353–361
Siewert JR, Stein HJ, Feith M (2003) Surgical approach to invasive adenocarcinoma of the distal esophagus (Barrett’s cancer). World J Surg 27: 1058–1061
Siewert JR, Feith M, Stein H (2005) Esophagectomy as therapeutic principle for squamous cell esophageal cancer. Chirurg 76:1033–1043
Sobin LH, Wittekind C (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York
Spechler SJ (2002) Clinical practice. Barrett’s esophagus. N Engl J Med 346: 836–842
Spechler SJ, Goyal RK (1996) The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 110: 614–621
Stahl M, Stuschke M, Lehmann N et al. (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317
Stahl M, Walz MK, Stuschke M et al. (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851–856
Stein HJ, Siewert JR (1993) Endobrachyösophagus: Pathogenese, Epidemiologie und maligne Degeneration. Dtsch Med Wochenschr 118: 511–519
Stein HJ, Siewert JR (1994) Klinische Bedeutung der Präkanzerosen des Ösophagus. In: Häring R (Hrsg) Krebsrisikoerkrankungen des Verdauungstrakts. Blackwell, Berlin, S 31–40
Stein HJ, Feith M (2001) Cancer of the esophagus. In Gospodarowicz M et al. (eds) Prognostic factors in cancer. Wiley-Liss Inc, New York, pp 237–249
Stein HJ and panel of experts (1996) Esophageal cancer: screening and surveillance. Results of a consensus conference. Dis Esoph 9[Suppl 1]: 3–19
Stein HJ, Kraemer SJM, Feussner H, Siewert JR (1997) Clinical value of diagnostic laparoscopy with laparoscopic ultrasound in patients with cancer of the esophagus or cardia. J Gastrointest Surg 1: 167–173
Stein HJ, Kauer WKH, Feussner H, Siewert JR (1998) Bile reflux in benign and malignant Barrett’s esophagus. Effect of medical acid suppression and fundoplication. J Gastrointest Surg 2: 333–341
Stein HJ, Feith M, Feussner H (2000a) The relationship between gastroesophageal reflux, development of Barrett’s epithelium and cancer of the esophagus. Langenbecks Arch Surg 385: 309–316
Stein HJ, Feith M, Siewert JR (2000b) Malignant degeneration of Barrett’s esophagus. Clinical point of view. Rec Res Cancer Res 155: 119–122
Stein HJ, Feith M, Müller J, Werner M, Siewert JR (2000c) Limited resection for early Barrett’s cancer. Ann Surg 232: 733–742
Stein HJ, Sendler A, Fink U, Siewert JR (2000d) Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am 80: 659–682
Stein HJ, Brücher BLDM, Feith M, Werner M, Molls M, Fink U, Roder JD (2000e) Ösophaguskarzinom. In: Roder JD, Stein HJ, Fink U (Hrsg) Therapie gastrointestinaler Tumoren. Prinzipien der chirurgischen Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München. Springer, Berlin Heidelberg New York Tokio, S 187–207
Stein HJ, Bartels H, Siewert JR (2001) Ösophaguscarcinom: Zweizeitiges Operieren als Mediastinitisprophylaxe beim Risikopatienten. Chirurg 72: 881–886
Stein HJ, Brücher BLDM, Sendler A, Siewert JR (2001) Esophageal cancer: Patient evaluation and pretreatment staging. Surg Oncol 10: 103–111
Stein HJ, Feith M, Siewert JR (2001) Distale Ösophagusresektion und Dünndarminterposition beim Frühcarcinom im Barrett Ösophagus. Zentralbl Chir 126: 9–13
Stein HJ, von Rahden BHA, Höfler H, Siewert JR (2003) Karzinom des ösophagogastralen Übergangs und Barrett Ösophagus-ein nahezu klares onkologisches Modell? Chirurg 74: 703–708
Stein HJ, Feith M, Siewert JR (2003) Approach to early Barrett’s cancer. World J Surg 27: 1040–1046
Stein HJ, Theisen J, Siewert JR (2003) Surgical resection for esophageal cancer: role of extended lymphadenectomy. In: Fielding JWL, Hallissey MT (eds) Upper gastrointestinal surgery. Springer, Berlin Heidelberg New York Tokyo
Theisen J, Stein HJ, Dittler HJ, Feith M, Moebius C, Kauer WKH, Werner M, Siewert JR (2002) Preoperative chemotherapy unmasks underlying Barrett’s mucosa in patients with adenocarcinoma of the distal esophagus. Surg End 16: 671–300
Theisen J, Peters JH, Stein HJ (2003) Experimental evidence for mutagenic potential of duodenogastric juice an Barrett’s esophagus. World J Surg 27: 1018–1020
Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19: 305–313
Urba S, Orringer M, Turrisi A, Whyte R, Iannettoni M, Forastiere A (1997) A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer: updated analysis. Proc Am Soc Clin Oncol 16: A 983
Walsh TN, Noonan N, Hollywood D et al. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335: 462–467
Weber WA, Ott K, Becker K, Dittler HJ, Helmberger H, Avril NE, Meisetschlager G et al. (2001) Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19: 3058–3065
Werner M, Flejou JF, Hainaut P, Höfler H, Lambert R, Keller G, Stein HJ (2000) Adenocarcinoma of the oesophagus. In: Hamilton SR, Aaltonen L (eds) World Health Organization classification of tumours: pathology and genetics-tumours of the digestive system. IARC, Lyon, pp 20–25
Zacherl J, Sendler A, Stein HJ, Ott K, Feith M, Jakesz R, Siewert JR, Fink U (2003) Current status of neoadjuvant therapy for adenocarcinoma of the distal esophagus. World J Surg 27: 1067–1074
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Siewert, J.R., Stein, H.J., Lordick, F. (2010). Ösophaguskarzinom. In: Siewert, J.R., Rothmund, M., Schumpelick, V. (eds) Praxis der Viszeralchirurgie Onkologische Chirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03808-2_38
Download citation
DOI: https://doi.org/10.1007/978-3-642-03808-2_38
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03807-5
Online ISBN: 978-3-642-03808-2
eBook Packages: Medicine (German Language)